Crystal structure of 6-(phenylsulfanyl)-5-propylpyrimidine-2,4(1H,3H)- dione, C13H14N2O2S

被引：0
作者：
Al-Omary, Fatmah A. M. [1 ]
Ghabbour, Hazem A. [1 ]
Attia, Mohamed I. [1 ]
Fun, Hoong-Kun [1 ,2 ]
El-Emam, Ali A. [1 ]
机构：
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
[2] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town 11800, Malaysia
来源：
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2015年 / 230卷 / 03期
关键词：
DERIVATIVES; 5-FLUOROURACIL; INHIBITORS; DESIGN;
D O I：
10.1515/ncrs-2015-0012
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
C13H14N2O2S, triclinic, P (1) over bar (no. 2), a = 10.0414(5) angstrom, b = 11.0866(6) angstrom, c = 12.6400(7) angstrom, alpha = 96.149(2)degrees, beta = 105.602(2)degrees, gamma = 110.432(2)degrees, V = 1238.2 angstrom(3), Z = 4, R-gt(F) = 0.0553, wR(ref)(F-2) = 0.1105, T = 150 K.
引用
收藏
页码：289 / 291
页数：3
相关论文
共 18 条
[1]   5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens [J].
Al Safarjalani, ON ;
Zhou, XJ ;
Rais, RH ;
Shi, JX ;
Schinazi, RF ;
Naguib, FNM ;
el Kouni, MH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (06) :541-551
[2]  
Al-Abdullah E S, 2014, Drug Res (Stuttg), V64, P31, DOI 10.1055/s-0033-1351315
[3]   Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents [J].
Al-Abdullah, Ebtehal S. ;
Al-Obaid, Abdul-Rahman M. ;
Al-Deeb, Omar A. ;
Habib, Elsayed E. ;
El-Emam, Ali A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) :4642-4647
[4]   5-Propyl-6-(p-tolylsulfanyl)pyrimidine-2,4(1H, 3H)-dione [J].
Al-Omary, Fatmah A. M. ;
Ghabbour, Hazem A. ;
El-Emam, Ali A. ;
Kumar, C. S. Chidan ;
Fun, Hoong-Kun .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 :0179-+
[5]  
[Anonymous], 2009, SAINT SADABS
[6]   3,4-DIHYDRO-2-ALKOXY-6-BENZYL-4-OXOPYRIMIDINES (DABOS) - A NEW CLASS OF SPECIFIC INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ARTICO, M ;
MASSA, S ;
MAI, A ;
MARONGIU, ME ;
PIRAS, G ;
TRAMONTANO, E ;
LACOLLA, P .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (06) :361-368
[7]  
El-Emam AA, 2004, B KOR CHEM SOC, V25, P991
[8]   An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug [J].
Ghoshal, K ;
Jacob, ST .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (11) :1569-1575
[9]   Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors [J].
Hopkins, AL ;
Ren, JS ;
Esnouf, RM ;
Willcox, BE ;
Jones, EY ;
Ross, C ;
Miyasaka, T ;
Walker, RT ;
Tanaka, H ;
Stammers, DK ;
Stuart, DI .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) :1589-1600
[10]   The design and synthesis of N-1-alkylated-5-aminoaryalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors [J].
Lu, Xiao ;
Chen, Yanli ;
Guo, Ying ;
Liu, Zhenming ;
Shi, Yawei ;
Xu, Yang ;
Wang, Xiaowei ;
Zhang, Zhili ;
Liu, Junyi .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (23) :7399-7407
12